Drug profile · INN
sofosbuvir + velpatasvir
EPCLUSA
sofosbuvir + velpatasvir (EPCLUSA) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
TGA: approved
Patents linked 0
Pipeline programs 3
News articles 1
Drug details — sofosbuvir + velpatasvir
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.81
Quick answer
sofosbuvir + velpatasvir (EPCLUSA) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Recent coverage
Pipeline programs
Frequently asked questions
What is sofosbuvir + velpatasvir?
sofosbuvir + velpatasvir (EPCLUSA) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
What is the brand name for sofosbuvir + velpatasvir?
EPCLUSA is a marketed brand name for sofosbuvir + velpatasvir. Check FDA Drugs@FDA for the current US label holder and prescribing information.